References
- Acar, M. F., Sari, S., & Dalkara, S. (2019). Synthesis, in vivo anticonvulsant testing, and molecular modeling studies of new nafimidone derivatives. Drug Development Research, 80(5), 606–616. https://doi.org/https://doi.org/10.1002/ddr.21538
- Beylkin, D., Kumar, G., Zhou, W., Park, J., Jeevan, T., Lagisetti, C., Harfoot, R., Webby, R. J., White, S. W., & Webb, T. R. (2017). Protein-structure assisted optimization of 4, 5-dihydroxypyrimidine-6-carboxamide inhibitors of influenza virus endonuclease. Scientific Reports, 7(1), 1–12. https://doi.org/https://doi.org/10.1038/s41598-017-17419-6
- Bıçak, B., Gündüz, S. K., Kökcü, Y., Özel, A. E., & Akyüz, S. (2019). Molecular docking and molecular dynamics studies of L-glycyl-L-glutamic acid dipeptide. Bilge International Journal of Science and Technology Research, 3(1), 1–9. https://doi.org/https://doi.org/10.30516/bilgesci.476841
- Bost, A. G., Carnahan, R. H., Lu, X. T., & Denison, M. R. (2000). Four proteins processed from the replicase gene polyprotein of mouse hepatitis virus colocalize in the cell periphery and adjacent to sites of virion assembly. Journal of Virology, 74(7), 3379–3387. https://doi.org/https://doi.org/10.1021/acs.biochem.5b01087 https://doi.org/https://doi.org/10.1128/JVI.74.7.3379-3387.2000
- Brockway, S. M., Clay, C. T., Lu, X. T., & Denison, M. R. (2003). Characterization of the expression, intracellular localization, and replication complex association of the putative mouse hepatitis virus RNA-dependent RNA polymerase. Journal of Virology, 77(19), 10515–10527. https://doi.org/https://doi.org/10.1128/jvi.77.19.10515-10527.2003
- Budama-Kilinc, Y., Cakir-Koc, R., Kecel-Gunduz, S., Zorlu, T., Kokcu, Y., Bicak, B., Karavelioglu, Z., & Ozel, A. E. (2018). Papain loaded poly(ε-caprolactone) nanoparticles: In-silico and in-vitro studies. Journal of Fluorescence, 28(5), 1127–1142. https://doi.org/https://doi.org/10.1007/s10895-018-2276-6
- Cai, Q., Yang, M., Liu, D., Chen, J., Shu, D., Xia, J., Liao, X., Gu, Y., Cai, Q., Yang, Y., Shen, C., Li, X., Peng, L., Huang, D., Zhang, J., Zhang, S., Wang, F., Liu, J., Chen, L., … Liu, L. (2020). Experimental treatment with favipiravir for COVID-19: An open-label control study. Engineering. https://doi.org/https://doi.org/10.1016/j.eng.2020.03.007
- Credille, C. V., Morrison, C. N., Stokes, R. W., Dick, B. L., Feng, Y., Sun, J., Chen, Y., & Cohen, S. M. (2019). SAR exploration of tight-binding inhibitors of influenza virus PA endonuclease. Journal of Medicinal Chemistry, 62(21), 9438–9449. https://doi.org/https://doi.org/10.1021/acs.jmedchem.9b00747
- Elfiky, A. A. (2020). Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study. Life Sciences, 253, 117592. https://doi.org/https://doi.org/10.1016/j.lfs.2020.117592
- Ertas, M., Sahin, Z., Bulbul, E. F., Bender, C., Biltekin, S. N., Berk, B., Yurttas, L., Nalbur, A. M., Celik, H., & Demirayak, Ş. (2019). Potent ribonucleotide reductase inhibitors: Thiazole‐containing thiosemicarbazone derivatives. Archiv Der Pharmazie, 352(11), 1900033. https://doi.org/https://doi.org/10.1002/ardp.201900033
- Fan, H., Walker, A. P., Carrique, L., Keown, J. R., Martin, I. S., Karia, D., Sharps, J., Hengrung, N., Pardon, E., Steyaert, J., Grimes, J. M., & Fodor, E. (2019). Structures of influenza A virus RNA polymerase offer insight into viral genome replication. Nature, 573(7773), 287–290. https://doi.org/https://doi.org/10.1038/s41586-019-1530-7
- Fodor, E. (2013). The RNA polymerase of influenza a virus: Mechanisms of viral transcription and replication. Acta Virologica, 57(2), 113–122. https://doi.org/https://doi.org/10.4149/av_2013_02_113
- Friesner, R. A., Banks, J. L., Murphy, R. B., Halgren, T. A., Klicic, J. J., Mainz, D. T., Repasky, M. P., Knoll, E. H., Shelley, M., Perry, J. K., Shaw, D. E., Francis, P., & Shenkin, P. S. (2004). Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. Journal of Medicinal Chemistry, 47(7), 1739–1749. https://doi.org/https://doi.org/10.1021/jm0306430
- Friesner, R. A., Murphy, R. B., Repasky, M. P., Frye, L. L., Greenwood, J. R., Halgren, T. A., Sanschagrin, P. C., & Mainz, D. T. (2006). Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. Journal of Medicinal Chemistry, 49(21), 6177–6196. https://doi.org/https://doi.org/10.1021/jm051256o
- Fudo, S., Yamamoto, N., Nukaga, M., Odagiri, T., Tashiro, M., & Hoshino, T. (2016). Two distinctive binding modes of endonuclease inhibitors to the N-terminal region of influenza virus polymerase acidic subunit. Biochemistry, 55(18), 2646–2660. https://doi.org/https://doi.org/10.1021/acs.biochem.5b01087
- Furuta, Y., Komeno, T., & Nakamura, T. (2017). Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase. Proceedings of the Japan Academy. Series B, Physical and Biological Sciences, 93(7), 449–463. https://doi.org/https://doi.org/10.2183/pjab.93.027
- Gupta, M. K., Vemula, S., Donde, R., Gouda, G., Behera, L., & Vadde, R. (2020). In-silico approaches to detect inhibitors of the human severe acute respiratory syndrome coronavirus envelope protein ion channel. Journal of Biomolecular Structure and Dynamics. https://doi.org/https://doi.org/10.1080/07391102.2020.1751300
- Harder, E., Damm, W., Maple, J., Wu, C., Reboul, M., Xiang, J. Y., Wang, L., Lupyan, D., Dahlgren, M. K., Knight, J. L., Kaus, J. W., Cerutti, D. S., Krilov, G., Jorgensen, W. L., Abel, R., & Friesner, R. A. (2016). OPLS3: A force field providing broad coverage of drug-like small molecules and proteins. Journal of Chemical Theory and Computation, 12(1), 281–296. https://doi.org/https://doi.org/10.1021/acs.jctc.5b00864
- Humphrey, W., Dalke, A., & Schulten, K. (1996). VMD: Visual molecular dynamics. Journal of Molecular Graphics, 14(1), 33–38. https://doi.org/https://doi.org/10.1016/0263-7855(96)00018-5
- Hunt, R. (2020). Coronaviruses, colds and sars. Microbiology and immunology. https://www.microbiologybook.org/virol/coronaviruses.htm
- Jin, Y., Yang, H., Ji, W., Wu, W., Chen, S., Zhang, W., & Duan, G. (2020). Virology, epidemiology, pathogenesis, and control of COVID-19. Viruses, 12(4), 372. https://doi.org/https://doi.org/10.3390/v12040372
- Jin, Z., Du, X., Xu, Y., Deng, Y., Liu, M., Zhao, Y., Zhang, B., Li, X., Zhang, L., Peng, C., Duan, Y., Yu, J., Wang, L., Yang, K., Liu, F., Jiang, R., Yang, X., You, T., Liu, X., … Yang, H. (2020). Structure of Mpro from COVID-19 virus and discovery of its inhibitors. Nature, 582, 289–293. https://doi.org/https://doi.org/10.1101/2020.02.26.964882
- Jorgensen, W. L., & Duffy, E. M. (2002). Prediction of drug solubility from structure. Advanced Drug Delivery Reviews, 54(3), 355–366. https://doi.org/https://doi.org/10.1016/S0169-409X(02)00008-X
- Kecel-Gunduz, S., Budama-Kilinc, Y., Cakir-Koc, R., Zorlu, T., Bicak, B., Kokcu, Y., Ozel, A. E., & Akyuz, S. (2020). In Silico design of AVP (4–5) peptide and synthesis, characterization and in vitro activity of chitosan nanoparticles. DARU: Journal of Faculty of Pharmacy, Tehran University of Medical Sciences, 28(1), 139–157. https://doi.org/https://doi.org/10.1007/s40199-019-00325-9
- Kirchdoerfer, R. N., & Ward, A. B. (2019). Structure of the SARS-CoV nsp12 polymerase bound to nsp7 and nsp8 co-factors. Nature Communications, 10(1), 1–9. https://doi.org/https://doi.org/10.1038/s41467-019-10280-3
- Kollman, P. A., Massova, I., Reyes, C., Kuhn, B., Huo, S., Chong, L., Lee, M., Lee, T., Duan, Y., Wang, W., Donini, O., Cieplak, P., Srinivasan, J., Case, D. A., Cheatham, T. E. 3rd., &, (2000). Calculating structures and free energies of complex molecules: Combining molecular mechanics and continuum models. Accounts of Chemical Research, 33(12), 889–897. https://doi.org/https://doi.org/10.1021/ar000033j
- Lim, J., S., Jeon, S., Shin, H. Y., Kim, M. J., Seong, Y. M., Lee, W. J., Choe, K. W., Kang, Y. M., Lee, B., & Park, S. J. (2020). Case of the index patient who caused tertiary transmission of COVID-19 infection in Korea: The application of lopinavir/ritonavir for the treatment of COVID-19 infected pneumonia monitored by quantitative RT-PCR. Journal of Korean Medical Science, 35(6), e79https://doi.org/https://doi.org/10.3346/jkms.2020.35.e79
- Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews, 23(1–3), 3–25. https://doi.org/https://doi.org/10.1016/S0169-409X(96)00423-1
- Menteşe, E., Emirik, M., & Sökmen, B. B. (2019). Design, molecular docking and synthesis of novel 5,6-dichloro-2-methyl-1H-benzimidazole derivatives as potential urease enzyme inhibitors. Bioorganic Chemistry, 86, 151–158. https://doi.org/https://doi.org/10.1016/j.bioorg.2019.01.061
- Mermer, A., Demirbas, N., Uslu, H., Demirbas, A., Ceylan, S., & Sirin, Y. (2019). Synthesis of novel Schiff bases using green chemistry techniques; antimicrobial, antioxidant, antiurease activity screening and molecular docking studies. Journal of Molecular Structure, 1181, 412–422. https://doi.org/https://doi.org/10.1016/j.molstruc.2018.12.114
- Mesecar, A. D. (2020). Structure of COVID-19 main protease bound to potent broad-spectrum non-covalent inhibitor X77. https://doi.org/https://doi.org/10.2210/pdb6w63/pdb
- Nelson, M. T., Humphrey, W., Gursoy, A., Dalke, A., Kalé, L. V., Skeel, R. D., & Schulten, K. (1996). NAMD: A parallel, object-oriented molecular dynamics program. The International Journal of Supercomputer Applications and High Performance Computing, 10(4), 251–268. https://doi.org/https://doi.org/10.1177/109434209601000401
- Nguyen, M., & Haenni, A. L. (2003). Expression strategies of ambisense viruses. Virus Research, 93(2), 141–150. https://doi.org/https://doi.org/10.1016/S0168-1702(03)00094-7
- Omoto, S., Speranzini, V., Hashimoto, T., Noshi, T., Yamaguchi, H., Kawai, M., Kawaguchi, K., Uehara, T., Shishido, T., Naito, A., & Cusack, S. (2018). Characterization of influenza virus variants induced by treatment with the endonuclease inhibitor baloxavir marboxil. Scientific Reports, 8(1), 1–15. https://doi.org/https://doi.org/10.1038/s41598-018-27890-4
- Sağlık, B. N., Çavuşoğlu, B. K., Osmaniye, D., Levent, S., Çevik, U. A., Ilgın, S., Özkay, Y., Kaplancıklı, Z. A., & Öztürk, Y. (2019b). In vitro and in silico evaluation of new thiazole compounds as monoamine oxidase inhibitors. Bioorganic Chemistry, 85, 97–108. https://doi.org/https://doi.org/10.1016/j.bioorg.2018.12.019
- Sağlık, B. N., Çevik, U. A., Osmaniye, D., Levent, S., Çavuşoğlu, B. K., Demir, Y., Ilgın, S., Özkay, Y., Koparal, A. S., Beydemir, Ş., & Kaplancıklı, Z. A. (2019a). Synthesis, molecular docking analysis and carbonic anhydrase I-II inhibitory evaluation of new sulfonamide derivatives. Bioorganic Chemistry, 91, 103153. https://doi.org/https://doi.org/10.1016/j.bioorg.2019.103153
- Sari, S., Barut, B., Özel, A., Kuruüzüm-Uz, A., & Şöhretoğlu, D. (2019). Tyrosinase and α-glucosidase inhibitory potential of compounds isolated from Quercus coccifera bark: In vitro and in silico perspectives. Bioorganic Chemistry, 86, 296–304. https://doi.org/https://doi.org/10.1016/j.bioorg.2019.02.015
- Schrödinger. (2019a). Schrödinger Release 2019-4: LigPrep. Schrödinger, LLC.
- Schrödinger. (2019b). Schrödinger Release 2019-4: Maestro. Schrödinger, LLC.
- Schrödinger. (2020). Schrödinger Release 2020-1: QikProp. Schrödinger, LLC.
- Singh, P., & Bast, F. (2014). In silico molecular docking study of natural compounds on wild and mutated epidermal growth factor receptor. Medicinal Chemistry Research, 23(12), 5074–5085. https://doi.org/https://doi.org/10.1007/s00044-014-1090-1
- Turkish Min. of Health. (2020). COVID-19 (SARS-CoV-2) infection guide science committee work. Republic of Turkey Ministry of Health Directorate General of Public Health. https://covid19bilgi.saglik.gov.tr/depo/rehberler/COVID-19_Rehberi.pdf
- World Health Organization. (2020). Coronavirus disease 2019 (COVID-19): Situation report, 67.